SMYD2 and breast cancer: To model metastatic colonization of the lung, we intravenously inoculated highly lung-metastatic prone MDA-MB-231 breast cancer cells with depletion of endogenous SMYD2 and/or BCAR3 complemented with WT or methyl-mutant K334A BCAR3.